COBRA: A prospective multimodal imaging study of dopamine, brain structure and function, and cognition.
2015 (English)In: Brain Research, ISSN 0006-8993, E-ISSN 1872-6240, Vol. 1612, 83-103 p.Article in journal (Refereed) Published
Cognitive decline is a characteristic feature of normal human aging. Previous work has demonstrated marked interindividual variability in onset and rate of decline. Such variability has been linked to factors such as maintenance of functional and structural brain integrity, genetics, and lifestyle. Still, few, if any, studies have combined a longitudinal design with repeated multimodal imaging and a comprehensive assessment of cognition as well as genetic and lifestyle factors. The present paper introduces the Cognition, Brain, and Aging (COBRA) study, in which cognitive performance and brain structure and function are measured in a cohort of 181 older adults aged 64 to 68 years at baseline. Participants will be followed longitudinally over a 10-year period, resulting in a total of three equally spaced measurement occasions. The measurement protocol at each occasion comprises a comprehensive set of behavioral and imaging measures. Cognitive performance is evaluated via computerized testing of working memory, episodic memory, perceptual speed, motor speed, implicit sequence learning, and vocabulary. Brain imaging is performed using positron emission tomography with [(11)C]-raclopride to assess dopamine D2/D3 receptor availability. Structural magnetic resonance imaging (MRI) is used for assessment of white and gray-matter integrity and cerebrovascular perfusion, and functional MRI maps brain activation during rest and active task conditions. Lifestyle descriptives are collected, and blood samples are obtained and stored for future evaluation. Here, we present selected results from the baseline assessment along with a discussion of sample characteristics and methodological considerations that determined the design of the study.
Place, publisher, year, edition, pages
2015. Vol. 1612, 83-103 p.
Aging, Cognitive decline, Striatum, Magnetic resonance imaging (MRI), Positron emission tomography (PET), [ 11C]-raclopride
IdentifiersURN: urn:nbn:se:umu:diva-93568DOI: 10.1016/j.brainres.2014.09.010ISI: 000356551700008PubMedID: 25239478OAI: oai:DiVA.org:umu-93568DiVA: diva2:749765